Walking on a thin line between potent platelet inhibition for myocardial infarction and risk of hemorrhagic complications. Tirofiban induced subconjunctival hemorrhage

Marie-Eva Laurencet; Juan F. Iglesias; Stéphane Noble; Elena Tessitore; Sophie Degrauwe

doi:10.5603/CJ.2021.0032

Vol 28, No 2 (2021)

Image in Cardiovascular Medicine

Submitted: 2020-12-21

Accepted: 2021-01-15

Published online: 2021-04-13

View PDF

Download PDF file

Get Citation

Walking on a thin line between potent platelet inhibition for myocardial infarction and risk of hemorrhagic complications. Tirofiban induced subconjunctival hemorrhage

Marie-Eva Laurencet¹, Juan F. Iglesias¹, Stéphane Noble¹

, Elena Tessitore¹, Sophie Degrauwe¹

DOI: 10.5603/CJ.2021.0032

Pubmed: 33881772

Cardiol J 2021;28(2):351-352.

Affiliations

Department of Cardiology, Geneva University Hospital, Geneva, Switzerland, Gabrielle- Perret-Gentil 4, 1205 Genève, Switzerland

Vol 28, No 2 (2021)

Images in cardiovascular medicine — Clinical cardiology

Submitted: 2020-12-21

Accepted: 2021-01-15

Published online: 2021-04-13

Abstract

Not available

Abstract

Not available

Full Text:

View PDF

Download PDF file

Get Citation

About this article

Title

Walking on a thin line between potent platelet inhibition for myocardial infarction and risk of hemorrhagic complications. Tirofiban induced subconjunctival hemorrhage

Journal

Cardiology Journal

Issue

Vol 28, No 2 (2021)

Article type

Image in Cardiovascular Medicine

Pages

351-352

Published online

2021-04-13

Page views

665

Article views/downloads

614

DOI

10.5603/CJ.2021.0032

Pubmed

33881772

Bibliographic record

Cardiol J 2021;28(2):351-352.

Authors

Marie-Eva Laurencet
Juan F. Iglesias
Stéphane Noble
Elena Tessitore
Sophie Degrauwe